http://ajpheart.physiology.org/content/early/2013/01/14/ajpheart.00712.2012.abstract
Abstract
During an ischemic stroke normal brain
endothelial function is perturbed resulting in blood brain barrier (BBB)
breakdown
with subsequent infiltration of activated
inflammatory blood cells, ultimately leading to neuronal cell death.
Kruppel-like
factor 2 (KLF2) is regulated by flow, is highly
expressed in vascular endothelial cells (ECs), and serves as a key
molecular
switch regulating endothelial function and
promoting vascular health. In this study we sought to determine the role
of KLF2
in cerebrovascular function and the pathogenesis of
ischemic stroke. Transient middle cerebral artery occlusion (tMCAO) was
performed in KLF2 deficient (KLF2-/-), KLF2 overexpressing (KLF2tg), and control mice and stroke volume analyzed. BBB function was assessed in vivo by real time neuroimaging using positron
emission tomography (PET) and Evan's blue dye (EBD) assay. KLF2-/- mice exhibited significantly larger strokes and impairment in BBB function. In contrast, KLF2tg
mice were protected against ischemic stroke and demonstrated preserved
BBB function. In concordance, gain and loss of function
studies in primary brain microvascular ECs using
transwell assays revealed KLF2 to be BBB protective. Mechanistically,
KLF2
was demonstrated, both in vitro and in vivo, to
regulate the critical BBB tight junction factor occludin. These data are
first
to identify endothelial KLF2 as a key regulator of
the BBB and a novel neuroprotective factor in ischemic stroke.
No comments:
Post a Comment